Are you Dr. Kurtis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St
Department Of Pathology Apc-12
Providence, RI 02903Phone+1 401-444-7241Fax+1 401-444-8514
Summary
- Dr. Jonathan Kurtis, MD is a board certified pathologist in Providence, Rhode Island. He is currently licensed to practice medicine in Rhode Island and Pennsylvania. He is affiliated with Rhode Island Hospital and Miriam Hospital.
Education & Training
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1997 - 2000
- The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
- RI State Medical License 2000 - 2026
- PA State Medical License 1998 - 2000
- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- Association of Antibodies to Helminth Defense Molecule 1 With Inflammation, Organomegaly, and Decreased Nutritional Status in Schistosomiasis Japonica.Amanda E Ruiz, Sunthorn Pond-Tor, Ronald Stuart, Luz P Acosta, Hannah M Coutinho
The Journal of Infectious Diseases. 2024-10-16 - Single cell transcriptional changes across the blood stages of artemisinin resistant K13upon dihydroartemisinin exposure.Cliff I Oduor, Sean V Connelly, Clark Cunningham, Nazrin Rustamzade, Jenna Zuromski
Biorxiv. 2024-09-06 - 1 citationsEvaluation of sensitivity and specificity of Kato-Katz and circulating cathodic antigen in terms of Schistosoma japonicum using latent class analysis.Mugyeom Moon, Hannah W Wu, Mario Jiz, Stephanie Maldonado, Jonathan D Kurtis
Scientific Reports. 2024-04-08
Press Mentions
- Ocean Biomedical Prices IPO at $7.00-$9.00 Per Share (OCEA)July 26th, 2021
- Research Reveals a New Malaria Vaccine CandidateApril 22nd, 2020